Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX

[1]  H. Isoniemi,et al.  Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[2]  J. Carpten,et al.  Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees. , 2001, Journal of lipid research.

[3]  C. Maslen,et al.  Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: polymerase chain reaction-based assays to simplify genotyping. , 2000, American journal of medical genetics.

[4]  F. Gabreëls,et al.  Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. , 2000, Brain : a journal of neurology.

[5]  F. Gabreëls,et al.  Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. , 1999, Metabolism: clinical and experimental.

[6]  G. Watts,et al.  Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. , 1997, The American journal of physiology.

[7]  H. Segev,et al.  Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family , 1995, Human Genetics.

[8]  Y. Tokimura,et al.  Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use , 1994, Journal of the Neurological Sciences.

[9]  G. Tint,et al.  Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis. , 1994, Metabolism: clinical and experimental.

[10]  Z. Meiner,et al.  Cerebrotendinous xanthomatosis , 1994, Neurology.

[11]  Y. Matsuzawa,et al.  Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. , 1991, Metabolism: clinical and experimental.

[12]  U. Francke,et al.  Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. , 1991, The Journal of biological chemistry.

[13]  J. C. van der Molen,et al.  Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. , 1991, Journal of lipid research.

[14]  M. Osame,et al.  High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis. , 1991, Journal of lipid research.

[15]  B. Kottke,et al.  Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells. , 1989, The Biochemical journal.

[16]  A. Quyyumi,et al.  Aneurysmal coronary artery disease in cerebrotendinous xanthomatosis. , 1988, The American journal of cardiology.

[17]  G. Tint,et al.  Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26. , 1985, The Journal of clinical investigation.

[18]  A. Batta,et al.  Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. , 1985, Journal of lipid research.

[19]  S. Shefer,et al.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. , 1984, The New England journal of medicine.

[20]  M. Une,et al.  Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis. , 1980, Journal of lipid research.

[21]  S. Shefer,et al.  Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid. , 1975, The Journal of clinical investigation.

[22]  S. Grundy,et al.  Metabolism of β-sitosterol in man , 1970 .

[23]  P. Swanson,et al.  Cerebrotendinous Xanthomatosis: The Storage of Cholestanol Within the Nervous System , 1968 .

[24]  A. Batta,et al.  Biosynthesis of Bile Acids in Cerebrotendinous Xanthomatosis , 1985 .

[25]  S. Shefer,et al.  Determination of hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity in man. , 1974, Journal of lipid research.

[26]  S. Grundy,et al.  Metabolism of beta-sitosterol in man. , 1970, The Journal of clinical investigation.